ISRCTN83050762已完成不适用
Quetiapine augmentation of a serotonin reuptake inhibitor in treatment resistant obsessive-compulsive disorder: a multi-site, placebo-controlled study
AstraZeneca (South Africa)0 个研究点目标入组 42 人开始时间: 2005年1月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects with obsessive-compulsive disorder who failed at least one trial (12 weeks duration, of which six weeks at maximum tolerated dose) of a serotonin reuptake inhibitor.
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Quetiapine augmentation to serotonin reuptake inhibitors for patients with obsessive compulsive disorder: a double-blind, placebo-controlled studyObsessive-Compulsive Disorder (OCD)Mental and Behavioural DisordersNeurotic disordersISRCTN40781401niversity Medical Centre Utrecht (UMCU) (The Netherlands)76
招募中
1 期
Selective serotonin reuptake inhibition in patients with advanced gastroesophageal cancer receiving immunochemotherapy: a prospective phase II trialgastroesophageal cancerEUCTR2022-001989-36-ATMed. Univ. Wien, Klinik f. Innere Med I, Onkologie35
已完成
不适用
Effect of serotonin-norepinephrine reuptake inhibitor on functional gastrointestinal disorder and evaluation of the brain function.JPRN-UMIN000023995Shimane University Faculty of Medicine Department of Psychiatry200
已完成
4 期
Effects of selective serotonin re-uptake inhibition on MOrbidity, mOrtality and mood in Depressed Heart Failure patientsHeart failure and co-morbid depressionMental and Behavioural DisordersISRCTN33128015German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)414
进行中（未招募）
不适用
Effects of an antidepressant drug on morbidity, mortality and mood in Depressed Heart Failure patientsEUCTR2007-006609-25-DEJulius Maximilians Universität Würzburg